Clinical Trials
3
Active:0
Completed:1
Trial Phases
1 Phases
Phase 4:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 4
2 (100.0%)Evaluation Of Vision Recovery And Comfort Index In Patients With Borderline/Mild Dry Eyes Undergoing FLACS With Premium IOL
Phase 4
- Conditions
- Dry Eye Syndromes
- Interventions
- First Posted Date
- 2021-04-28
- Last Posted Date
- 2021-04-28
- Lead Sponsor
- Sight Medical Doctors PLLC
- Target Recruit Count
- 30
- Registration Number
- NCT04863742
- Locations
- 🇺🇸
SightMD, LIASC, Brentwood, New York, United States
OCT Evaluation of Neurotrophic Ulcer Following Treatment With Oxervate
Recruiting
- Conditions
- Neurotrophic KeratoconjunctivitisNeurotrophic Corneal UlcerNeurotrophic KeratitisNeurotrophic Ulcer
- Interventions
- First Posted Date
- 2020-10-05
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Sight Medical Doctors PLLC
- Target Recruit Count
- 10
- Registration Number
- NCT04573647
- Locations
- 🇺🇸
SightMD, Manhasset, New York, United States
Intracanalicular Dexamethasone Insert for Post-Corneal Cross-Linking Inflammation and Pain- The LINK Study
Phase 4
Completed
- Conditions
- Postoperative PainKeratoconus, UnstableCollagen Crosslinking
- Interventions
- First Posted Date
- 2019-11-19
- Last Posted Date
- 2024-01-30
- Lead Sponsor
- Sight Medical Doctors PLLC
- Target Recruit Count
- 20
- Registration Number
- NCT04168112
- Locations
- 🇺🇸
SightMD, Babylon, New York, United States
News
No news found